Rathke, H., Giesel, F. L., Flechsig, P., Mier, W., Hohenfellner, M., Haberkorn, U., & Kratochwil, C. (2018). Repeated 177Lu-labeled PSMA-617 radioligand therapy using treatment activities of up to 9.3 GBq. Journal of nuclear medicine, 59(3), . https://doi.org/10.2967/jnumed.117.194209
Chicago-Zitierstil (17. Ausg.)Rathke, Hendrik, Frederik L. Giesel, Paul Flechsig, Walter Mier, Markus Hohenfellner, Uwe Haberkorn, und Clemens Kratochwil. "Repeated 177Lu-labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq." Journal of Nuclear Medicine 59, no. 3 (2018). https://doi.org/10.2967/jnumed.117.194209.
MLA-Zitierstil (9. Ausg.)Rathke, Hendrik, et al. "Repeated 177Lu-labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq." Journal of Nuclear Medicine, vol. 59, no. 3, 2018, https://doi.org/10.2967/jnumed.117.194209.